Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
Not yet recruiting
- Conditions
- Recurrent Ovarian Cancer
- Registration Number
- NCT06070285
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to support their widespread adoption.
By actively participating in recurrent ovarian cancer observational study serves pivotal role in expanding the boundaries of medical knowledge and advancing the quality of care provided to those enduring the same condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old
- Able to comprehend the investigational nature of the protocol and provide informed consent
- Diagnosis of recurrent ovarian cancer
Exclusion Criteria
- No diagnosis of recurrent ovarian cancer confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to participate in a recurrent ovarian cancer clinical trial 3 months Rate of patients who remain in recurrent ovarian cancer clinical research to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States